What is the recommended treatment for streptococcal pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Streptococcal Pharyngitis

Penicillin or amoxicillin remains the first-line treatment for streptococcal pharyngitis due to proven efficacy, safety, narrow spectrum, and low cost. 1

First-Line Treatment for Patients Without Penicillin Allergy

Oral penicillin V or amoxicillin for 10 days is the gold standard treatment. 1, 2

Specific Dosing Regimens:

Penicillin V (oral): 1, 2

  • Children: 250 mg two or three times daily for 10 days
  • Adolescents and adults: 250 mg four times daily OR 500 mg twice daily for 10 days

Amoxicillin (oral): 1, 2

  • 50 mg/kg once daily (maximum 1,000 mg) for 10 days
  • Alternative: 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days
  • Amoxicillin is often preferred in young children due to better taste acceptance 1

Intramuscular benzathine penicillin G (single dose): 1, 2

  • Patients <60 lb (27 kg): 600,000 units
  • Patients ≥60 lb: 1,200,000 units
  • This option is particularly important for patients unlikely to complete oral therapy or in settings where compliance cannot be assured 1, 3

Evidence Supporting Once-Daily Amoxicillin:

Recent high-quality evidence demonstrates that once-daily amoxicillin (750 mg for children <40 kg, 1000 mg for ≥40 kg) is non-inferior to twice-daily dosing, with bacteriologic failure rates of 20.1% at 14-21 days and only 2.8% at 28-35 days. 4 This regimen offers improved convenience and comparable efficacy to traditional multi-dose regimens. 5

Treatment for Patients With Penicillin Allergy

The choice of alternative antibiotic depends on whether the patient has immediate-type (anaphylactic) hypersensitivity to penicillin. 1, 6, 7

For Non-Anaphylactic Penicillin Allergy:

First-generation cephalosporins are the preferred alternative: 1, 6, 7

  • Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days
  • Cefadroxil: 30 mg/kg once daily (maximum 1 g) for 10 days

For Immediate/Anaphylactic Penicillin Allergy:

Avoid cephalosporins due to up to 10% cross-reactivity risk. 7 Use one of the following:

Clindamycin: 1, 6, 7

  • 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days
  • Particularly effective for chronic carriers with resistance rates around 1% in the United States 7

Azithromycin: 1, 6, 8

  • 12 mg/kg once daily (maximum 500 mg) for 5 days
  • Only macrolide requiring just 5 days due to prolonged tissue half-life 7, 8
  • Clinical success rates of 98% at Day 14 and 94% at Day 30 in controlled trials 8

Clarithromycin: 1, 6

  • 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days

Critical Diagnostic Considerations

Testing should be performed for patients with clinical features suggesting streptococcal infection: 2

  • Sudden onset of sore throat
  • Fever
  • Tonsillopharyngeal inflammation or exudates
  • Tender anterior cervical lymphadenopathy
  • Age 5-15 years

Avoid testing and treatment when viral features predominate: 1, 2

  • Cough, rhinorrhea, hoarseness, conjunctivitis, or oral ulcers strongly suggest viral etiology 1

A positive rapid antigen detection test (RADT) is diagnostic and requires no backup culture in adults. 1 However, negative RADT results in children and adolescents should be confirmed with throat culture. 1, 2

Important Resistance and Efficacy Considerations

Macrolide resistance among Group A Streptococcus varies geographically, with approximately 5-8% resistance in the United States. 1, 7 In areas with high macrolide resistance, cephalosporins or clindamycin are preferred over macrolides for penicillin-allergic patients. 7

Cephalosporins demonstrate lower clinical relapse rates compared to penicillin (OR 0.55; 95% CI 0.31-0.99), though symptom resolution is comparable. 1

Short-course macrolides show greater risk of late bacteriological recurrence (OR 1.31; 95% CI 1.16-1.48) compared to 10-day penicillin courses. 1

Adjunctive Therapy

NSAIDs or acetaminophen can be used for moderate to severe symptoms or high fever. 1, 2 NSAIDs are more effective than acetaminophen for pain and fever control. 9

Avoid aspirin in children due to risk of Reye syndrome. 1, 2

Corticosteroids are not recommended for routine use as they provide only minimal symptom reduction. 1, 9

Management of Recurrent Pharyngitis

For patients with recurrent positive cultures shortly after treatment completion: 1

  • Retreat with the same antimicrobial agent initially used
  • If compliance with oral therapy is questionable, use intramuscular benzathine penicillin G
  • Consider clindamycin or amoxicillin-clavulanate for suspected chronic carriers 6

Distinguish true recurrent infections from chronic carriers experiencing viral infections. 6 Chronic carriers generally do not require antimicrobial therapy as they are unlikely to spread infection or develop complications. 7

Common Pitfalls to Avoid

Do not perform routine post-treatment throat cultures in asymptomatic patients who have completed therapy. 1, 2 Follow-up testing is only indicated in special circumstances such as patients with history of rheumatic fever. 7

Do not routinely test or treat asymptomatic household contacts. 1

Do not prescribe antibiotics for likely viral pharyngitis based on clinical features (cough, rhinorrhea, hoarseness, oral ulcers). 2

Do not use trimethoprim-sulfamethoxazole for streptococcal pharyngitis due to high resistance rates (50%). 7

Ensure full 10-day courses for all antibiotics except azithromycin to achieve maximal pharyngeal eradication and prevent rheumatic fever. 1, 2 Shorter courses (except azithromycin's 5-day regimen) lead to treatment failure and complications. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Streptococcal Pharyngitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Recurrent Streptococcal Pharyngitis in Patients with Amoxicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Common Questions About Streptococcal Pharyngitis.

American family physician, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.